[After the LDL receptor and apolipoprotein B, autosomal dominant hypercholesterolemia reveals its third protagonist: PCSK9].
about
Living the PCSK9 adventure: from the identification of a new gene in familial hypercholesterolemia towards a potential new class of anticholesterol drugs.Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9).Plasma PCSK9 levels are significantly modified by statins and fibrates in humansLow prevalence of mutations in known loci for autosomal dominant hypercholesterolemia in a multiethnic patient cohort.A new method for measurement of total plasma PCSK9: clinical applications.Effect of E670G Polymorphism in PCSK9 Gene on the Risk and Severity of Coronary Heart Disease and Ischemic Stroke in a Tunisian Cohort.
P2860
[After the LDL receptor and apolipoprotein B, autosomal dominant hypercholesterolemia reveals its third protagonist: PCSK9].
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
[After the LDL receptor and ap ...... its third protagonist: PCSK9].
@ast
[After the LDL receptor and ap ...... its third protagonist: PCSK9].
@en
[After the LDL receptor and ap ...... its third protagonist: PCSK9].
@nl
type
label
[After the LDL receptor and ap ...... its third protagonist: PCSK9].
@ast
[After the LDL receptor and ap ...... its third protagonist: PCSK9].
@en
[After the LDL receptor and ap ...... its third protagonist: PCSK9].
@nl
prefLabel
[After the LDL receptor and ap ...... its third protagonist: PCSK9].
@ast
[After the LDL receptor and ap ...... its third protagonist: PCSK9].
@en
[After the LDL receptor and ap ...... its third protagonist: PCSK9].
@nl
P50
P1476
[After the LDL receptor and ap ...... its third protagonist: PCSK9]
@en
P2093
M Abifadel
P304
P356
10.1016/J.ANDO.2007.02.002
P407
P577
2007-03-27T00:00:00Z